Press Releases

VIDEO: MPP Jim Wilson Continues to Press for CF drugs

February 17, 2021 Simcoe-Grey MPP Jim Wilson has repeated his call for governments to cut through bureaucracy standing in the way of Ontario Cystic Fibrosis patients who are fighting for medications that would allow them to lead longer and healthier lives. Trikafta became the latest CF gene-modulating drug submitted to Health Canada for approval in December, and it is now undergoing priority review.  It could be approved within six months. 

Questioning Health Minister Christine Elliott, Mr. Wilson expressed concern that Trikafta will run into the same delays that two other Cystic Fibrosis therapies face.  Both Orkambi and Symdeko have been approved for sale in Canada, but have been subject to drawn out pricing negotiations since May 2020.  The pan-Canadian Pharmaceutical Alliance represents provincial, territorial and federal governments in reimbursement talks with drug manufacturers. 

Trikafta has been approved in 32 countries and is paid for in the United States, the United Kingdom, Ireland, Austria, Denmark, Germany, and Slovenia. 

Minister Elliott recognized that people living with CF are anxious to see the life-saving drugs made available in Ontario.  And she said, when they are, the government will move quickly to ensure they are listed on the Ontario Drug Benefit Formulary.

You can watch MPP Wilson’s exchange with Minister Elliott here:


Ontario's Debt Clock

Email Signup

COVID-19

Get the most up to date information on the 2019 Novel Coronavirus (COVID-19).

ONTARIO'S RESPONSE CANADA'S RESPONSE